Early Recognition and Therapy Centre for Beginning Psychoses Bochum, Department of Psychiatry, Psychotherapy and Psychosomatic Medicine, Ruhr-University of Bochum, Bochum, Germany.
J Psychiatry Neurosci. 2010 Jan;35(1):33-40. doi: 10.1503/jpn.090013.
Accumulating evidence from postmortem and magnetic resonance imaging (MRI) studies suggests that abnormalities of medial temporal lobe structures are critically involved in the pathogenesis of schizophrenia. It is still unclear, however, whether certain abnormalities are already present in individuals at ultra high-risk (UHR) for transition into psychosis. Recent studies involving patients at UHR showed contradictory results for hippocampal volume, and only 1 study reported that amygdalar volume was unchanged between healthy patients and those at UHR. Furthermore, no subregions of the hippocampus have been investigated in people at UHR.
We recruited 29 UHR patients, 23 first-episode patients and 29 age- and sex-matched healthy controls. We measured hippocampal and amygdalar volumes from MRI scans by use of BRAINS2 to manually trace the regions of interest. The hippocampi were divided in 2 regions: head and corpus/tail.
Patients at UHR had significantly smaller volumes of the hippocampus corpus and tail bilaterally, but not of the head, compared with healthy controls. Group differences for the right hippocampus corpus and tail volume remained significant after we controlled for whole brain volume and other covariates. We found that UHR patients who later developed psychosis had smaller right hippocampus corpus and tail volumes than did those who did not develop psychosis. First-episode patients had significantly smaller left amygdalar volumes than did healthy individuals or those at UHR.
Our study had a small sample size, and we were unable to control for the effects of medication.
Our findings suggest that parts of the hippocampal-amygdalar complex are involved in the pathogenesis of schizophrenia. Reduction of hippocampus corpus and tail volumes may be indicative of the prodromal phase of schizophrenia and represent risk factors for transition into psychosis. Further investigations are needed to determine whether structural changes of the left amygdala play a role during transition from the prodromal phase to the first manifest episode of schizophrenia.
越来越多的尸检和磁共振成像(MRI)研究证据表明,内侧颞叶结构的异常与精神分裂症的发病机制密切相关。然而,目前尚不清楚某些异常是否已经存在于处于精神病前期(UHR)的个体中。最近涉及 UHR 患者的研究显示,海马体体积存在矛盾的结果,只有 1 项研究报告称,健康患者和 UHR 患者之间杏仁核体积没有变化。此外,尚未在 UHR 人群中研究海马体的亚区。
我们招募了 29 名 UHR 患者、23 名首发患者和 29 名年龄和性别匹配的健康对照组。我们使用 BRAINS2 从 MRI 扫描中测量海马体和杏仁核的体积,通过手动追踪感兴趣的区域。将海马体分为 2 个区域:头部和体部/尾部。
与健康对照组相比,UHR 患者双侧海马体体部和尾部的体积明显较小,但头部体积无差异。在控制全脑体积和其他协变量后,右侧海马体体部和尾部体积的组间差异仍然显著。我们发现,后来发展为精神病的 UHR 患者的右侧海马体体部和尾部体积明显小于未发展为精神病的患者。首发患者的左侧杏仁核体积明显小于健康个体或 UHR 患者。
我们的研究样本量较小,且无法控制药物的影响。
我们的研究结果表明,海马体-杏仁核复合体的某些部分与精神分裂症的发病机制有关。海马体体部和尾部体积的减少可能是精神分裂症前驱期的指标,也是向精神病转变的风险因素。需要进一步的研究来确定左侧杏仁核的结构变化在从前驱期到精神分裂症首次显性发作的过渡中是否起作用。